"Biotechnologijų projektai", MB Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statetment report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Working capital requirement |
Debt-to-equity ratio |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2020 |
---|
83,739 |
- |
1,085 |
889 |
- |
0.54 |
0.27 |
29.00 |
1.06 |
49,200 |
13,487 |
3,913 |
58,774 |
2021 |
---|
120,066 |
- |
19,608 |
16,650 |
- |
0.52 |
0.31 |
36.37 |
13.87 |
65,851 |
20,438 |
3,719 |
82,570 |
Register and
explore Okredo data2021 |
---|
120,066 |
- |
19,608 |
16,650 |
- |
0.52 |
0.31 |
36.37 |
13.87 |
65,851 |
20,438 |
3,719 |
82,570 |
Register and
explore Okredo data2021
Turnover (€)
120,066 €43 % *
Sales per employee (€)
-Profit before tax (€)
19,608 €1,707 % *
Net Profit (€)
16,650 €1,773 % *
Profit per employee (€)
-Working capital requirement
0.52 -3.70 % *
Debt-to-equity ratio
0.31 14.81 % *
Total profitability (%)
36.37 %25.41 % *
Net profitability (%)
13.87 %1,208.49 % *
Equity (€)
65,851 €34 % *
Amounts Payable And Liabilities (€)
20,438 €52 % *
Non-current Assets (€)
3,719 €-5 % *
CurrentAssets (€)
82,570 €40 % *